- Visibility 180 Views
- Downloads 23 Downloads
- DOI 10.18231/j.ijpo.2024.077
-
CrossMark
- Citation
Analysis of clinical and histopathological differences between right and left sided colon cancers
- Author Details:
-
Avantika Kailu
-
Bawana Raina *
-
Chakshu Mahajan
Introduction
Colorectal cancer (CRC) is the third most common cancer worldwide.[1] Most colon cancers are sporadic, and approximately 5 percent are due to an inherited genetic mutation which includes Lynch syndrome (Hereditary nonpolyposis colon cancer or HNPCC) and familial adenomatous polyposis (FAP). It takes several years for the transition of normal colonic epithelium into an invasive cancer which requires accumulation of genetic mutations, adenoma formation and subsequent carcinogenesis.[2] The other risk factors include increasing age, family history, inflammatory bowel disease (IBD) and various environmental and lifestyle factors. Following the diagnosis of ulcerative colitis in a patient, the annual incidence of colon cancer is 0.5% in the first 10 to 20 years which increases to 1% per year after that. Crohn disease increases the cancer risk if present in the ileocolic region.[3] The various lifestyle factors which increase the risk of colon cancer are alcohol consumption, cigarette smoking, obesity, diets rich in processed red meat, insulin resistance, history of prior radiation and immunosuppression.[4] Colon cancers are divided into two groups based on the location of the primary tumor. It is a heterogenous disease, with notable differences between right sided colon cancer (RCC) and left sided colon cancer (LCC). Anatomical and developmental origins, unique carcinogenic causes or a mix of both may account for the differences between these tumor.[5] These variations impact prognosis and treatment strategies and thus, the present study was undertaken to determine the various clinicopathological differences between RCC and LCC.
Aim and Objective
This study aimed to analyse and compare the clinical and histopathological features of RCC and LCC in a cohort of 80 patients, focusing on demographic characteristics, clinical presentation and tumor pathology.
Materials and Methods
This study was designed as a retrospective cohort analysis to investigate the clinical and histopathological differences between right -sided colon cancers (RCC) and left sided colon cancers (LCC) in 80 cases. The study included 80 patients diagnosed with colon cancer, with 40 RCC and 40 LCC cases. The clinical histories were obtained from the medical records of the patients at American Oncology Institute, Jammu and their respective histopathologic specimens were received in our department of pathology. Various parameters were compared which included demographic information like age at diagnosis and gender, clinical symptoms like anemia, weight loss, changes in bowel habits and rectal bleeding. Various histopathologic features were evaluated like tumor size, histologic type, grade, stage, lymphovascular invasion and perineural invasion.
Statistical analysis
Data analysis was conducted using SPSS software version 19.0. Descriptive statistics were used to summarize demographic and clinical characteristics. Independent t- tests were used to compare continuous variables (age, tumor size) between RCC and LCC groups. Chi square tests were employed to compare categorical variables (gender, clinical presentation, histologic grade, tumor stage, lymphovascular invasion and perineural invasion). A p- value of less than 0.05 was considered statistically significant.
Inclusion criteria
Patients aged 18 years or older at the time of diagnosis.
Tumors located in the right colon (caecum, ascending colon, hepatic flexure) or left colon (splenic flexure, descending colon, sigmoid colon).
Patients who have undergone surgical resection for the colon cancer.
Exclusion criteria
History of other malignancies.
Incomplete medical records
Neoadjuvant chemotherapy
Results
This study compares the clinicopathological characteristics of right-sided colon cancer (RCC) and left-sided colon cancer (LCC) in 80 cases. The data was analysed to identify significant differences between the two groups.
Characteristic |
RCC (n = 40) |
LCC (n = 40) |
p-value |
Age (Mean ± SD) |
68 ± 8 years |
64 ± 7 years |
0.02* |
Gender |
|
|
|
Female |
24 (60%) |
18 (45%) |
0.18 |
Male |
16 (40%) |
22 (55%) |
|
Clinical Feature |
RCC (n = 40) |
LCC (n = 40) |
p-value |
Anemia |
20 (50%) |
8 (20%) |
0.006* |
Weight Loss |
16 (40%) |
6 (15%) |
0.01* |
Changes in Bowel Habits |
6 (15%) |
20 (50%) |
0.001* |
Rectal Bleeding |
4 (10%) |
16 (40%) |
0.002* |
Gross features
Tumor appearance
RCC: Tumors in RCC often appeared as larger, exophytic masses that can grow into the lumen of the colon, sometimes with ulceration.
LCC: LCC tumors were more commonly circumferential, leading to a "napkin-ring" or constrictive appearance, which can cause obstruction.
Although the study did not quantify the exact percentage of exophytic versus circumferential appearances, these descriptions are consistent with general findings in colon cancer literature.


Histologic Type |
RCC (n = 40) |
LCC (n = 40) |
p-value |
Adenocarcinoma |
30 (75%) |
32 (80%) |
0.78 |
Mucinous Adenocarcinoma |
6 (15%) |
4 (10%) |
0.73 |
Signet Ring Cell Carcinoma |
3 (7.5%) |
2 (5%) |
0.64 |
Others |
1 (2.5%) |
2 (5%) |
0.55 |
Interpretation of histologic type
Adenocarcinoma: This is the most common histologic type in both RCC and LCC. In this study, 75% of RCC cases and 80% of LCC cases were classified as adenocarcinoma, with no significant difference between the two groups (p = 0.78).
Mucinous adenocarcinoma: The incidence of mucinous adenocarcinoma was slightly higher in RCC (15%) compared to LCC (10%), though the difference was not statistically significant (p = 0.73). Mucinous adenocarcinoma is known to be more commonly associated with RCC, and while our study reflects this trend, the sample size may not be sufficient to demonstrate a significant difference.
Signet ring cell carcinoma: This rare and aggressive subtype was observed in 7.5% of RCC cases and 5% of LCC cases, with no significant difference between the groups (p = 0.64). Signet ring cell carcinoma is typically associated with poor prognosis and often presents at a more advanced stage.
Other histologic types: Rare histologic types such as medullary and squamous cell carcinoma were observed in a small number of cases (2.5% in RCC and 5% in LCC). These types are uncommon in colorectal cancer, and the distribution in our study did not show a significant difference (p = 0.55).



Pathological Feature |
RCC (n = 40) |
LCC (n = 40) |
p-value |
Tumor Size (Mean ± SD) |
6.2 ± 1.4 cm |
4.5 ± 1.1 cm |
0.001* |
High-grade Tumors |
16 (40%) |
8 (20%) |
0.04* |
Low-grade Tumors |
24 (60%) |
32 (80%) |
0.04* |
Tumor (Stage pT) |
|
|
|
- Stage T1/T2 |
14 (35%) |
22 (55%) |
0.08 |
- Stage T3/T4 |
26 (65%) |
18 (45%) |
|
Lymphovascular Invasion |
8 (20%) |
14 (35%) |
0.15 |
Perineural Invasion |
6 (15%) |
6 (15%) |
1.00 |
These results underscore the importance of recognizing the distinct clinicopathological features of RCC and LCC, which can aid in tailored approaches to screening, diagnosis, and treatment.
Discussion
According to Saltzstein et al.,[6] aging was linked to a shift in the anatomic site of colon cancer from the left to the right side. This aligns with present study that has reported older age at diagnosis for RCC (68±8 years) compared to LCC (64±7 years). The youngest patients had tumors in their sigmoid colons, while the oldest patients had tumors in their caecums.[7] This finding is most likely explainable by a delay in the right side of the colon's cancer diagnosis.
In a study by Gonzalez EC et al.,[8] there was more female preponderance than males. Gender distribution did not differ significantly between RCC and LCC in our study, with a slight predominance of females in the RCC group and males in the LCC group. According to Vayrynen J.P. et al.,[9] anemia is commonly seen in RCC patients than in LCC patients, regardless of sex, which may be related to variations in genetic instability. Anemia in CRC is mostly caused by chronic blood loss. RCC patients were more likely to present with anemia (50% vs. 20%, p = 0.006) and weight loss (40% vs. 15%, p = 0.01) in our study as well. LCC patients reported changes in bowel habits (50% vs. 15%, p = 0.001) and rectal bleeding (40% vs. 10%, p = 0.002) in the present study. In a study by Bourakkadi Idrissi M,[10] left-sided colon cancers presented with rectal bleeding more often which was in accordance to our study. However, the changes in bowel habits were mostly observed in patients with RCC.
RCC tumors were significantly larger than LCC tumors (6.2 ± 1.4 cm vs. 4.5 ± 1.1 cm, p = 0.001). The histologic type distribution between RCC and LCC in this study did not show statistically significant differences, though there was a trend toward a higher incidence of mucinous adenocarcinoma in RCC. In a study by Zenger S et al.,[11] right sided colon cancers were diagnosed mostly with mucinous type of cancer while left sided colon cancer was diagnosed as adenocarcinoma. It is more common for the histological patterns (mucinous adenocarcinoma) seen in right colon cancers to be linked to faults in the mismatch DNA repair pathway.[12] Larger tumor size in RCC has been reported in other studies and may be related to delayed symptom onset and diagnosis in the right colon. Additionally, RCC had a higher proportion of high-grade tumors (40% vs. 20%, p = 0.04) and a lower proportion of low-grade tumors (60% vs. 80%, p = 0.04) compared to LCC. This suggests that RCC may exhibit more aggressive behaviour, which is supported by molecular studies indicating differences in genetic and epigenetic alterations between RCC and LCC. In a study by Hsu Y-L et al.,[13] Patients with right-sided colon cancers had a more advanced Tumor stage and were poorly differentiated tumors. The presence of lymphovascular and perineural invasion was similar in both groups, indicating that these features may not be specific to tumor location but rather to tumor biology
The tumor's anatomical location has a significant impact on its behavior, which in turn influences its molecular and immunological features. It is crucial to comprehend the attributes of these two distinct entities in order to create medicines that work.[14], [15]
Conclusion
This study underscores the significant clinicopathological differences between RCC and LCC. Recognizing these differences is vital for improving diagnostic accuracy, optimizing treatment strategies, and ultimately enhancing patient outcomes. Future research should focus on elucidating the underlying molecular mechanisms driving these differences and exploring targeted therapeutic approaches.
Source of Funding
None.
Conflict of Interest
None.
References
- M Arnold, MS Sierra, M Laversanne, I Soerjomataram, A Jemal, F Bray. Global patterns and trends in colorectal cancer incidence and mortality. Gut 2017. [Google Scholar]
- M Gajendran, P Loganathan, G Jimenez, AP Catinella, N Ng, C Umapathy. A comprehensive review and update on ulcerative colitis. Dis Mon 2019. [Google Scholar]
- RJ Birch, N Burr, V Subramanian, JP Tiernan, MA Hull, P Finan. Inflammatory Bowel Disease-Associated Colorectal Cancer Epidemiology and Outcomes: An English Population-Based Study. Am J Gastroenterol 2022. [Google Scholar]
- NY Loh, W Wang, R Noordam, C Christodoulides. Obesity, fat distribution and risk of cancer in women and men: a Mendelian randomisation study. Nutrients 2009. [Google Scholar]
- OK Glebov, LM Rodriguez, K Nakahara, J Jenkins, J Cliatt, CJ Humbyrd. Distinguishing right from left colon by the pattern of gene expression. Cancer Epidemiol Biomarkers Prev 2003. [Google Scholar]
- SL Saltzstein, CA Behling. Age and time as factors in the left-to-right shift of the subsite of colorectal adenocarcinoma: a study of 213,383 cases from the California Cancer Registry. J Clin Gastroenterol 2007. [Google Scholar]
- P Gervaz, P Bucher, P Morel. Two colons-two cancers: paradigm shift and clinical implications. J Surg Oncol 2004. [Google Scholar]
- EC Gonzalez, RG Roetzheim, JM Ferrante, R Campbell. Predictors of proximal vs. distal colorectal cancers. Dis Colon Rectum 2001. [Google Scholar]
- JP Väyrynen, A Tuomisto, SA Väyrynen, K Klintrup, T Karhu, J Mäkelä. Preoperative anemia in colorectal cancer: relationships with tumor characteristics, systemic inflammation, and survival. Sci Rep 2018. [Google Scholar]
- MB Idrissi, HE Bouhaddouti, O Mouaqit, A Ousadden, KA Taleb, EB Benjelloun. Left-Sided Colon Cancer and Right-Sided Colon Cancer: Are They the Same Cancer or Two Different Entities?. Cureus 2023. [Google Scholar]
- S Zenger, B Gürbüz, U Can, Ç Bilgiç, E Sobutay, E Balık, D Buğra. Differences Between Right and Left Colon Cancers in Terms of Clinicopathological Features and Long-term Oncological Outcomes. Turkish Journal of Colorectal Disease 2020. [Google Scholar]
- ZK Stadler. Diagnosis and management of DNA mismatch repair-deficient colorectal cancer. Hematol Oncol Clin North Am 2015. [Google Scholar]
- YL Hsu, CC Lin, JK Jiang, HH Lin, YT Lan, HS Wang. Clinicopathological and molecular differences in colorectal cancer according to location. Int J Biol Markers 2019. [Google Scholar]
- IO Hansen, P Jess. Possible better long-term survival in left versus right-sided colon cancer - a systematic review. Dan Med J 2012. [Google Scholar]
- P Jess, IO Hansen, M Gamborg, T Jess. A nationwide Danish cohort study challenging the categorisation into right-sided and left-sided colon cancer. BMJ Open 2013. [Google Scholar]